Nls pharmaceutics appoints keith harrison dewedoff as interim chief financial officer

ZÜrich, switzerland / accesswire / may 8, 2023 / nls pharmaceutics ltd. (nasdaq:nlsp)(nasdaq:nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that keith harrison dewedoff has been appointed to the position of interim chief financial officer ("cfo").
NLSP Ratings Summary
NLSP Quant Ranking